3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-02 16:12 UTC
Summit Therapeutics announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo to test their cancer drug Datroway in combination with Summit's ivonescimab. The combination will be tested across multiple tumor types, including lung and breast cancers.
News 2026-10-02 06:42 UTC
AstraZeneca and Daiichi Sankyo have entered into a clinical collaboration with Summit Therapeutics.
News 2026-10-02 06:30 UTC
Summit Therapeutics announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo to evaluate ivonescimab, an investigational PD-1 / VEGF bispecific antibody, in combination with Datroway.